UK Markets open in 3 hrs 22 mins
  • NIKKEI 225

    29,665.42
    -174.29 (-0.58%)
     
  • HANG SENG

    24,221.54
    +122.40 (+0.51%)
     
  • CRUDE OIL

    70.51
    -0.05 (-0.07%)
     
  • GOLD FUTURES

    1,778.30
    +0.10 (+0.01%)
     
  • DOW

    33,919.84
    -50.63 (-0.15%)
     
  • BTC-GBP

    32,565.74
    -2,671.21 (-7.58%)
     
  • CMC Crypto 200

    1,042.40
    -21.45 (-2.02%)
     
  • Nasdaq

    14,746.40
    +32.49 (+0.22%)
     
  • ^FTAS

    4,029.01
    +42.11 (+1.06%)
     

Global Urolithiasis Management Devices Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

·3-min read

DUBLIN, July 26, 2021--(BUSINESS WIRE)--The "Urolithiasis Management Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Urolithiasis Management Devices estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.

Extracorporeal Shock Wave Lithotripsy (ESWL), one of the segments analyzed in the report, is projected to record a 4.4% CAGR and reach US$842.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intracorporeal Lithotripsy segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $416.7 Million, While China is Forecast to Grow at 7.4% CAGR

The Urolithiasis Management Devices market in the U.S. is estimated at US$416.7 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$437.9 Million by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Percutaneous Nephrolithotomy Segment to Record 4.6% CAGR

In the global Percutaneous Nephrolithotomy segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$254.8 Million in the year 2020 will reach a projected size of US$343.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$283.1 Million by the year 2027, while Latin America will expand at a 5% CAGR through the analysis period.

Select Competitors (Total 42 Featured):

  • Boston Scientific

  • Cook Medical

  • Cybersonics

  • Direxgroup

  • Dornier

  • Elmed

  • Karl Storz

  • MTS Medical

  • Olympus

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/mx1ott

View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005661/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting